A retrospective real-world analysis presented at the 2025 ASH Annual Meeting and Exposition showed that circulating tumor DNA (ctDNA) detected at the end of treatment (EOT) was a prognostic indicator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback